Source:http://www.reactome.org/biopax/48887BiochemicalReaction2708
Predicate | Object |
---|---|
rdf:type | |
biopax3:comment |
Authored: Garapati, P V, 2010-08-02,
CYLD is an ovarian tumor (OTU) domain-containing deubiquitinating enzyme (DUB) and has been identified as a negative regulator of RIG-I mediated antiviral signaling. CYLD associates with the CARD domain of RIG-I and removes K63-linked ubiquitin from the RIG-I CARDs that are conjugated by the E3 ubiquitin ligase, TRIM25 and RNF135.,
Edited: Garapati, P V, 2010-08-22,
Reviewed: Kawai, T, Akira, S, 2010-10-30
|
biopax3:xref | |
biopax3:dataSource | |
biopax3:displayName |
CYLD mediated deubiquitination of RIG-I
|
biopax3:left | |
biopax3:right |